USPTO serial 78844612
V
Reviewed by CopyMark Law Group
Reg. 3564733Status 710
- Filing date
- Status date
- Registration date
- Jan 20, 2009
- Examiner
- MILTON, PRISCILLA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with V?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chippenham, Wiltshire, GB
Chippenham, Wiltshire, GB
Chippenham, Wiltshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARK HARRISON
MARK HARRISON VENABLE LLP575 7TH ST NWWASHINGTON, DC 20004-1607UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; powders for asthma inhalers; powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations in the nature of pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma | SECTION 8 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary apparatus, instruments and parts and fittings therefor, namely, drug delivery devices and parts and fittings therefor; inhalers for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapy and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; dispensing devices for the metering and/or dispensing of orally ingestible drugs for medical or therapeutic purposes and parts and fittings therefor; aerosol dispensers for medical or therapeutic purposes and parts and fittings therefor | SECTION 8 - CANCELLED | — |
| 016 | Paper, cardboard and goods made from these materials, namely, pharmaceutical packaging; printed matter, namely, books, magazines, journals, newsletters in the field of pharmaceutical preparations and medical apparatus and drug delivery devices; photographs; stationery; printed instructional and teaching material in the field of pharmaceutical preparations and medical apparatus and drug delivery devices; plastic materials for packaging namely bags and bubble packs; all the aforesaid being goods relating to pharmaceuticals or drug delivery devices | SECTION 8 - CANCELLED | — |
| 041 | Education services, namely, providing of training, lectures and symposia all relating to pharmaceuticals or drug delivery devices | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and technological services in the field of medicine, pharmaceuticals and drug delivery systems; industrial analysis and research services relating to medicine, pharmaceuticals and drug delivery systems; pharmaceutical development services; device and product safety testing services; preparation and/or formulation of pharmaceuticals, namely, development of medical applications, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations and consultation regarding pharmaceutical formulation | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vectura Limited
- Other trademarks owned by Vectura Limited
- Other trademarks owned by Vectura Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named V
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 21, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 20, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 4, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 15, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 26, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 26, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Nov 29, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2007 | PAPER RECEIVED | — | |
| May 10, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 14, 2007 | PAPER RECEIVED | — | |
| Sep 14, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 13, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 20, 2006 | MDSM | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Mar 29, 2006 | NWAP | NEW APPLICATION ENTERED | — |